The prognostic utility of pre-treatment 18F-FDG-PET for salvage re-irradiation in head and neck cancer patients

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

The prognostic utility of pre-treatment 18F-FDG-PET for salvage re-irradiation in head and neck cancer patients

12th World Cancer Conference

September 26-28, 2016 London, UK

Kateryna Musaieva

Clinical Hospital ├ó┬?┬?Feofaniya├ó┬?┬Ł, Ukraine

Posters & Accepted Abstracts: J Cancer Sci Ther

Abstract :

Aim: Statistical image features of tumor metabolism from pretreatment 18F-FDG-PET/CT scans were studied for their potential to predict clinical outcome of salvage re-irradiation with intensity modulated radiotherapy (IMRT) for recurrent squamous cell carcinoma of head and neck (HNSCC). Materials & Methods: Pretreatment PET/CT scans and after treatment PET/CT scans of patients who underwent IMRT reirradiation for recurrent HNSCC, were retrospectively evaluated. Metabolic response was assessed using PET response criteria for solid tumors (PERCIST). Multiple statistical image features related to the standard uptake value (SUV) were computed: Metabolic tumor volume, maximum SUV, mean SUV, total lesion glycolysis (TLG). The correlation between the image features and local control and overall survival was calculated. Results: Complete tumor metabolic response (CMR) was achieved in 5 patients (45.5%). Six patients failed to achieve CMR: Progressive metabolic disease was in 4 patients (36.4%); stable metabolic disease in one patient (9.1%); one patient had partial metabolic response (9.1%). The median follow-up time was 18.2 months. Out of the calculated image features, only pretreatment tumor TLG (individual tumor volume multiplied by its mean SUV) correlated with tumor metabolic response in the early PET/CT follow-up. Also dividing the patient population based on the median tumor TLG showed a split of the Kaplan- Meier survival curves. Conclusions: The tumor TLG of pre-treatment PET/CT scans has important information on the failure risk to achieve CMR in recurrent HNSCC patients. It is necessary to obtain additional patients data to validate these results.

Biography :


Google Scholar citation report
Citations: 3968

Cancer Science & Therapy received 3968 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

arrow_upward arrow_upward